GDRX Q3'26 Earnings: revenue estimate is 202.07M USD

What happened

GoodRx Holdings is scheduled to announce its Q3'26 results on November 10, with the release expected at 7:00 AM ET. Analysts estimate revenue of 202.07 million USD and earnings per share, or profit allocated to each share, of 0.08 USD.

Confirmed

Global impact / market context

The estimates give investors a benchmark for judging whether GoodRx’s reported sales and per-share profit meet expectations. A revenue or profit shortfall could weigh on views of the company’s ability to generate cash, while results above estimates could strengthen confidence in its performance.

Analyst inference

GoodRx’s upcoming results connect directly to its reported revenue and earnings per share, a measure of profit allocated to each share. If results differ from estimates, investors may reassess expectations for the company’s ability to generate revenue and profit, although the article gives no actual outcome.

Analyst inference

What to watch

1. Check the November 10 release for actual Q3'26 revenue and compare it with the 202.07 million USD estimate to see whether sales met expectations. Confirmed
2. Compare reported earnings per share with the 0.08 USD estimate; a difference would change how investors assess the quarter’s profit relative to forecasts. Confirmed
3. Look for management’s explanation of sales and profit trends, since guidance could shape expectations for future revenue and the cash GoodRx can generate. Analyst inference

Evidence

• Original source link unavailable